News related to
research

Rabdan Academy, a prominent institution specializing in safety, security, defence, emergency preparedness, and crisis management, has formalized a training agreement with INTERPOL. This collaboration aims to bolster cooperation in research, training, and the exchange of expertise between the two entities.

With the signing of this agreement, Rabdan Academy officially joins the INTERPOL Global Academy Network, a consortium dedicated to elevating training standards for law enforcement agencies worldwide through collaborative efforts and knowledge sharing among leading institutions.

The partnership outlines a framework for both organizations to identify and develop joint training activities and projects. These initiatives will encompass courses, seminars, conferences, curricula development, study tours, and train-the-trainer programs, all designed to enhance the capabilities of law enforcement personnel globally.

His Excellency James Anthony Morse, President of Rabdan Academy, emphasized the strategic importance of this alliance, stating that it aligns with the Academy’s mission to develop specialized skills and capabilities in relevant fields. He highlighted that collaboration with key international and local partners is essential for achieving this goal.

INTERPOL’s Secretary General, His Excellency Valdecy Urquiza, underscored the value of partnering with esteemed academic institutions like Rabdan Academy. He noted that such collaborations are vital for developing comprehensive global training methodologies and standards for law enforcement, benefiting INTERPOL’s member countries and enhancing the effectiveness of the Global Academy Network.

The agreement includes commitments to jointly develop training materials and curricula, exchange academic and training resources, and share expertise and faculty members. This cooperative approach aims to create robust training opportunities and foster applied research on topics pertinent to law enforcement.

Students at Rabdan Academy will gain access to courses and training tools from the INTERPOL Virtual Academy, enriching their proficiency in international policing. Additionally, Rabdan Academy’s training programs will receive accreditation from INTERPOL, ensuring they meet global standards of excellence.

This partnership was formalized during the International Defence Exhibition 2025, where Rabdan Academy is actively participating as an exhibitor. IDEX 2025 serves as a platform for showcasing the latest advancements in defence technology and fostering collaborations among global security stakeholders.

Rabdan Academy’s involvement in IDEX 2025 underscores its commitment to shaping the future of defence and security. The Academy is showcasing its specialized programs in safety, security, and crisis management, highlighting its role as a hub of expertise that brings together policymakers, defence leaders, and global experts to address evolving security challenges.

In addition to its partnership with INTERPOL, Rabdan Academy is set to announce new global collaborations aimed at strengthening its leadership in security and defence education. These initiatives reflect the Academy’s dedication to fostering expertise and cooperation to enhance global security efforts.

The INTERPOL Global Academy Network, established in 2019, is a collective of trusted law enforcement education institutions committed to providing a unified approach to law enforcement training. Rabdan Academy’s inclusion in this network signifies a significant step toward enhancing the quality and reach of specialized training programs for law enforcement professionals worldwide.

Through this partnership, both Rabdan Academy and INTERPOL aim to address contemporary challenges in law enforcement by leveraging their combined expertise and resources. The collaborative efforts are expected to result in the development of innovative training solutions that are responsive to the dynamic nature of global security threats.

As part of the agreement, there will be a concerted focus on applied research, enabling both institutions to contribute to the body of knowledge in law enforcement practices. This research component is poised to inform policy decisions and operational strategies, thereby enhancing the effectiveness of law enforcement agencies across different jurisdictions.

The Abu Dhabi Investment Office has entered into a strategic partnership with China’s leading financial information services provider, Wind Information, to enhance investment intelligence and deepen economic relations between Abu Dhabi and China. This collaboration was formalized during the Abu Dhabi Investment Forum held in Shanghai, underscoring Abu Dhabi’s commitment to strengthening its economic connections with China’s financial sector.

As part of the agreement, Wind Information will serve as ADIO’s preferred knowledge partner in China, offering investors improved access to the dynamic investment landscapes of both regions. The partnership aims to facilitate the exchange of financial market intelligence and investment insights, providing Chinese investors and family offices with comprehensive research and analysis on key market opportunities. Wind Information will actively link ADIO with prominent investors and financial institutions in China, while ADIO will assist Abu Dhabi-based investors in exploring prospects within the Chinese market. Additionally, both organizations plan to co-host investment forums in the UAE and China to promote opportunities and strengthen bilateral ties.

His Excellency Badr Al Olama, Director-General of ADIO, emphasized the significance of this partnership, stating that it reinforces Abu Dhabi’s dedication to enhancing economic ties with China and creating a seamless investment ecosystem. He highlighted that by providing access to market data and financial insights, Abu Dhabi ensures an environment where investors can thrive, make informed decisions, and contribute to the sustainable growth of both economies.

Li Zhou, Co-Founder of Wind Information, expressed commitment to connecting capital markets and investment opportunities between China and the world. He noted that the collaboration with ADIO would empower investors with data-driven insights, enhancing the investment corridor between China and the UAE.

In a related development, ADIO has also signed a strategic partnership with Fosun International Limited, a global innovation-driven consumer group, to expedite the expansion of Fosun’s subsidiaries into Abu Dhabi and the broader Middle East. This agreement, announced at the same forum in Shanghai, aims to strengthen economic ties and reinforce Abu Dhabi’s position as a global investment hub.

Under this partnership, ADIO will offer tailored investor support, streamlined market access, and strategic guidance to accelerate Fosun’s presence in key growth sectors within Abu Dhabi, including wealth management, fintech, premium residential real estate, and healthcare innovation. Fosun International, with a revenue of approximately $13.4 billion in the first half of 2024 and a global workforce exceeding 110,000 employees, operates across various industries such as pharmaceuticals, healthcare, tourism, insurance, financial services, and intelligent manufacturing. By establishing Abu Dhabi as a regional gateway to the Middle East, Africa, and Southeast Asia, Fosun aims to leverage the emirate’s dynamic business ecosystem and substantial investor base.

ADIO has entered into a strategic partnership with Hejun Group, one of China’s leading consulting firms, to accelerate Chinese investment in Abu Dhabi. This agreement, also announced at the Abu Dhabi Investment Forum in Shanghai, paves the way for high-growth enterprises to expand into Abu Dhabi’s thriving business environment.

Hejun Group, operating both consulting and capital activities under Hejun Capital, manages more than $2 billion in cumulative assets. The firm will introduce Abu Dhabi’s investment opportunities to its network of over 2,000 publicly listed companies and leading private enterprises in China. ADIO will provide dedicated support to these Chinese companies, facilitating their business setup and long-term growth in Abu Dhabi.

The Abu Dhabi Investment Forum in Shanghai, organized by ADIO in partnership with Abu Dhabi Global Market , served as a platform for in-depth discussions on investment opportunities in Abu Dhabi. The forum, themed “Invest with Abu Dhabi,” brought together business leaders and investors to explore the emirate’s growth potential. As one of the fastest-growing economies in the Middle East and North Africa, Abu Dhabi has increasingly become a key destination for international investments.

During the forum, participants engaged in discussions on Abu Dhabi’s role as a global financial, trade, and technology hub. Experts analyzed the emirate’s economic competitiveness and highlighted its strategic position in global capital flows, emphasizing its stable economic environment, flexible regulatory framework, and well-developed financial infrastructure, which make it an attractive destination for investors worldwide.

The discussions also addressed Abu Dhabi’s expanding role in facilitating international trade and strengthening global supply chains. Participants explored the emirate’s rapid advancements in technological innovation, particularly in financial technology, artificial intelligence, blockchain, and digital transformation.

The cryptocurrency platform Pump.fun has experienced a significant decline in daily trading volume, coinciding with the controversy surrounding Argentine President Javier Milei’s endorsement of the LIBRA memecoin. Data indicates that Pump.fun’s daily trading volume decreased by 27%, falling from $184 million to $134 million, following the promotion of LIBRA on February 14, 2025.

President Milei’s endorsement of LIBRA led to a rapid surge in the token’s market capitalization, reaching approximately $4 billion. However, the token’s value plummeted shortly thereafter, resulting in substantial financial losses for investors. This incident has sparked widespread criticism and calls for President Milei’s impeachment. He has defended his actions, stating that he was not fully informed about the token and acted in good faith.

The LIBRA memecoin was launched on February 14, 2025, with the intention of supporting small and mid-sized businesses in Argentina. President Milei promoted the token on his social media account, describing it as a promising investment opportunity. The token’s value experienced a brief surge before collapsing, leading to allegations of fraud and a significant financial impact on investors.

In the aftermath of the LIBRA incident, Pump.fun’s trading activity has notably declined. The platform’s daily trading volume fell by 27%, from $184 million to $134 million, as of February 19, 2025. This downturn reflects a broader trend of decreased activity in the memecoin market, possibly influenced by the negative publicity surrounding the LIBRA scandal.

Further complicating the situation, blockchain researchers have reported that approximately $99 million worth of cryptocurrency was withdrawn from the LIBRA marketplace by eight digital wallets linked to the token’s creator. These withdrawals have raised questions about the legitimacy of the token and the intentions of its creators.

The LIBRA incident has also prompted legal and political repercussions. Over 100 complaints have been filed against President Milei in Argentina’s supreme court, alleging financial misconduct and fraud. Opposition parties are calling for his impeachment, accusing him of irresponsibly promoting a fraudulent investment scheme. President Milei has denied any wrongdoing, asserting that he did not benefit financially from the promotion and was unaware of the token’s potential risks.

President Donald Trump has announced plans to impose tariffs of 25% or more on imported pharmaceuticals, automobiles, and semiconductors, aiming to reduce the U.S. trade deficit and bolster domestic manufacturing. The tariffs are slated for formal announcement on April 2, following a comprehensive review of trade policies concluding on April 1. This move signifies a significant shift in U.S. trade policy, as pharmaceutical products have traditionally been exempt from such tariffs under World Trade Organization rules.

The U.S. pharmaceutical market, valued at approximately $560 billion in 2024, relies heavily on imports, with around $200 billion worth of pharmaceutical products sourced from abroad. Major suppliers include Ireland, Germany, and Switzerland, which are expected to be significantly impacted by the proposed tariffs. India, another key exporter, sent pharmaceutical goods worth $8.73 billion to the U.S. in the fiscal year 2024, accounting for 31% of its total pharmaceutical exports. Following the tariff announcement, Indian pharmaceutical stocks experienced a notable decline, with the sector’s index dropping 2% to a seven-month low. Companies such as Sun Pharma and Dr. Reddy’s Laboratories saw their shares fall by 2% and 4%, respectively.

Industry experts warn that these tariffs could lead to increased drug prices for U.S. consumers and exacerbate existing medication shortages. The Healthcare Distribution Alliance , representing pharmaceutical distributors, expressed concerns that tariffs on generic drug products developed outside the U.S. could worsen shortages and elevate costs for patients, including those in Medicare and Medicaid programs. The HDA emphasized that distributors operate on low profit margins—approximately 0.3%—limiting their ability to absorb additional costs.

The global pharmaceutical supply chain is intricately linked, with many active pharmaceutical ingredients and raw materials sourced from countries like China and India. Approximately 13% of APIs used in the U.S. originate from China. Imposing tariffs on these imports could disrupt the supply chain, leading to production delays and increased manufacturing costs. Caroline Shleifer, CEO of regulatory research firm RegASK, noted that higher raw material costs are likely to cascade through the supply chain, raising overall production expenses and potentially leading to inflationary pressures in healthcare.

The proposed tariffs also pose challenges for domestic manufacturers. While the intent is to encourage companies to relocate production to the U.S., establishing new manufacturing facilities is a complex and time-consuming process. It requires significant investment in infrastructure, adherence to stringent regulatory approvals, and a skilled workforce. In the interim, consumers may face higher prices and limited access to essential medications.

The tariffs could have broader economic implications, potentially triggering retaliatory measures from affected trading partners. Such trade disputes may lead to a contraction in global trade, affecting not only the pharmaceutical industry but also other sectors interconnected through international supply chains. The uncertainty surrounding these developments has already led to volatility in global stock markets, with investors closely monitoring the situation.